Skip to main content
TLX logo
TLX
(NASDAQ)
Telix Pharmaceuticals Limited
$9.13-- (--)
Loading... - Market loading

Telix Pharmaceuticals (TLX) Stock Price & Financial Analysis

Telix Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.99 - $9.24
52-Week High$20.00
52-Week Low$6.28
Open$9.11
Volume169.89K
Average Volume (3M)169.89K
Market Cap3.15B
Shares Outstanding345.19M
P/E Ratio (TTM)102.75
Price to Sales (P/S)6.55
Price to Book (P/B)7.56
EV/EBITDA58.50
Revenue (TTM)487.02M
Net Income (TTM)31.04M
Free Cash Flow (TTM)5.47M
EPS (TTM)$0.09
Profit Margin6.37%
Operating Margin10.40%
Return on Equity (ROE)7.36%
Debt to Equity0.91
50-Day MA$7.66
200-Day MA$10.19
52-Week Change-44.70%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateApr 18, 2006

Frequently Asked Questions About Telix Pharmaceuticals

What is the current stock price for TLX?

As of the latest trading session, TLX stock trades at $9.13. The 52-week range is $6.28–$20.00, with a day range of $8.99–$9.24.

What is the P/E ratio for TLX?

Telix Pharmaceuticals's trailing P/E ratio is 102.8, meaning investors pay $102.8 for every $1 of annual earnings. Telix Pharmaceuticals operates in the Healthcare sector.

Does TLX pay dividends?

Telix Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TLX?

Based on 2 analysts, the consensus for TLX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TLX?

Telix Pharmaceuticals's market capitalization is $3.15B, classifying it as a mid-cap company. Telix Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.